Skip to main content

Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.

Publication ,  Journal Article
Prabhu, V; Kathe, N; Saxena, K; Walia, A; Markan, R; Myers, E; Einstein, M
Published in: Curr Med Res Opin
September 2021

INTRODUCTION: Human papillomavirus (HPV) cause cancers in a variety of anatomic sites presenting at various stages of disease. Current economic assessments rely on HPV-related cancer cost estimates from data prior to the launch of the nonavalent HPV vaccine (2014). The goal of the present study was to assess and describe the current direct medical care burden of HPV-related cancers in the US. METHODS: Using Clinformatics Data Mart, patients in the US who were newly diagnosed with cervical, vulvar, vaginal, anal, and oropharyngeal cancers between 2012 and 2015 were compared to non-cancer matched (propensity score) controls. Health care resource utilization and direct medical cost (2020 USD) were assessed over a 2-year follow-up period following index diagnosis from a payer perspective. The cost for censored time was estimated using generalized linear model while adjusting for survival probability using cox-proportional hazard model. Confidence intervals were calculated with bootstrapping technique. RESULTS: The analyses included 4128 cervical, 1580 vulvar, 538 vaginal, 1827 anal, and 6106 oropharyngeal cancers and matched controls. Cases and controls had similar baseline clinical characteristics and length of follow-up. The 2-year incremental direct medical costs were $93,272, $81,676, $141,096, $129,366, and $134,045 for cervical, vulvar, vaginal, anal, and oropharyngeal cancers respectively. Outpatient care costs was the biggest driver of the total incremental medical costs. Most cancer costs were incurred during the first 6 months of follow-up and then stabilized during follow-up. CONCLUSION: HPV-related cancers are responsible for substantial health care expenditure each year.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Curr Med Res Opin

DOI

EISSN

1473-4877

Publication Date

September 2021

Volume

37

Issue

9

Start / End Page

1599 / 1607

Location

England

Related Subject Headings

  • Vulvar Neoplasms
  • United States
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Papillomaviridae
  • Oropharyngeal Neoplasms
  • Humans
  • Health Care Costs
  • General & Internal Medicine
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Prabhu, V., Kathe, N., Saxena, K., Walia, A., Markan, R., Myers, E., & Einstein, M. (2021). Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States. Curr Med Res Opin, 37(9), 1599–1607. https://doi.org/10.1080/03007995.2021.1932447
Prabhu, Vimalanand, Niranjan Kathe, Kunal Saxena, Anuj Walia, Riddhi Markan, Evan Myers, and Mark Einstein. “Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.Curr Med Res Opin 37, no. 9 (September 2021): 1599–1607. https://doi.org/10.1080/03007995.2021.1932447.
Prabhu V, Kathe N, Saxena K, Walia A, Markan R, Myers E, et al. Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States. Curr Med Res Opin. 2021 Sep;37(9):1599–607.
Prabhu, Vimalanand, et al. “Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.Curr Med Res Opin, vol. 37, no. 9, Sept. 2021, pp. 1599–607. Pubmed, doi:10.1080/03007995.2021.1932447.
Prabhu V, Kathe N, Saxena K, Walia A, Markan R, Myers E, Einstein M. Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States. Curr Med Res Opin. 2021 Sep;37(9):1599–1607.

Published In

Curr Med Res Opin

DOI

EISSN

1473-4877

Publication Date

September 2021

Volume

37

Issue

9

Start / End Page

1599 / 1607

Location

England

Related Subject Headings

  • Vulvar Neoplasms
  • United States
  • Papillomavirus Vaccines
  • Papillomavirus Infections
  • Papillomaviridae
  • Oropharyngeal Neoplasms
  • Humans
  • Health Care Costs
  • General & Internal Medicine
  • Female